Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-19EMA Authorised: Opdivo (nivolumab) — Bristol-Myers Squibb Pharma EEIG
European Medicines Agency authorises Opdivo (nivolumab) for multiple cancer indications, including melanoma, non-small cell lung cancer, ren…
-
EMA approval · 2026-07-01EMA Authorised: Keytruda (pembrolizumab) — Merck Sharp & Dohme B.V.
EMA authorises Keytruda (pembrolizumab) for multiple cancer indications, including melanoma, Hodgkin disease, renal cell carcinoma, non-smal…
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating magrolimab plus pembrolizumab in relapsed or refractory classic Hodgkin lymphoma has been terminated with results p…
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety, tolerability, drug levels, and preliminary efficacy of relatlimab plus nivolumab in pediatric and young a…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating brentuximab vedotin in combination with bendamustine for Hodgkin lymphoma and anaplastic large cell lymphoma comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating CAR.70, engineered IL-15-transduced cord blood-derived natural killer (NK) cells, in combination with…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Methionine PET/CT Studies In Patients With Cancer [Phase 2]
Phase 2 methionine-based PET/CT imaging studies in patients with various cancers; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
An NCI-sponsored trial characterizes individuals and families at high risk of hematologic cancers, focusing on conditions including Waldenst…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
This clinical trial entry describes a study to establish a tumor bank in families with multiple lymphoproliferative malignancies and is curr…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tissue Collection for Studies of Lymph Cancer
Clinical trial update describing tissue collection for studies of lymph cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma [Phase 2]
Phase 2 trial update on CD70 CAR NK cells for primary refractory or early-relapsed diffuse large B-cell lymphoma and Hodgkin lymphoma; the s…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of BV-AVD in People With Bulky Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating BV-AVD in patients with bulky Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma [NA]
An update on a clinical trial evaluating adaptive proton therapy for pediatric solid tumors and Hodgkin lymphoma. The trial is currently not…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
Clinical trial update focused on obstructive sleep apnea in survivors of Hodgkin lymphoma treated with thoracic radiation. The trial is curr…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers [Phase 1]
Phase 1 safety study update for PF-08046044/SGN-35C in adults with advanced cancers; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer [NA]
Trial update indicates the NCT05550948 study on transcranial photobiomodulation to improve cognition in childhood cancer survivors is curren…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 [Phase 2]
The update notes that the pediatric Hodgkin lymphoma Phase 2 trial cHOD17, sponsored by St. Jude Children's Research Hospital, is currently …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma [NA]
This clinical trial update assesses the feasibility of high-intensity interval training for survivors of Hodgkin lymphoma diagnosed in child…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
A recruiting clinical study evaluating cardiopulmonary function and cerebral blood flow in Hodgkin lymphoma survivors, sponsored by St. Jude…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
This is a clinical trial update describing a longitudinal study that assesses frailty in young adult survivors of childhood cancer; the stud…
-
EMA approval · 2026-04-22EMA Authorised: Keytruda (pembrolizumab) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Keytruda (pembrolizumab) for multiple cancer indications, including melanoma, Hodgkin lymphoma, ren…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab [Phase 3]
A Phase 3 clinical trial comparing standard therapy for limited-stage Hodgkin lymphoma to a regimen incorporating Brentuximab Vedotin and Ni…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Biology Studies of Hematologic Cancers
The document reports an NCI-sponsored biology-focused clinical trial update in hematologic cancers, with enrollment by invitation for condit…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. [Phase 1, Phase 2]
This document describes a Phase 1/Phase 2 clinical trial evaluating AZD3470 as a monotherapy or in combination with other anticancer agents …
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
A completed clinical trial update detailing a genome expression study in leukemia, multiple myeloma, and lymphomas (Hodgkin and Non-Hodgkin)…